Study links hs-cTnT to MACE, mortality in rheumatoid arthritis

For patients with rheumatoid arthritis (RA), a detectable level of high-sensitivity cardiac troponin T (hs-cTnT) is associated with increased risk of major adverse cardiovascular events (MACE) and all-cause mortality, according to a research letter published online June 15 in the Journal of Rheumatology. Brittany N. Weber, M.D., Ph.D., from Brigham and Women’s Hospital in Boston, and colleagues examined the longer-term association between clinically established thresholds for detectable hs-cTnT with MACE (acute coronary syndrome, stroke, and cardiovascular death) and all-cause mortality among 331 patients with RA. The median calculated 10-year atherosclerotic Read More

Related posts:

  1. Rheumatoid arthritis patients with mono-, oligo-arthritis, high PGA remain most fatigued
  2. Study identifies molecular profile of rheumatoid arthritis patients with increased cardiovascular risk
  3. The impact of lifestyle intervention in rheumatoid arthritis
  4. A novel cinnamaldehyde nanomedicine for rheumatoid arthritis treatment
  5. Early rheumatoid arthritis: Disease trajectories and pain
  6. New work on precursors of inflammatory synovial macrophages sheds light on pathogenesis of rheumatoid arthritis
  7. Triglyceride-glucose index independently links all-cause mortality
  8. Study links psoriasis to OCD

Leave a Reply

Your email address will not be published. Required fields are marked *